… used extensively to develop point-of-care and highly sensitive methods of cancer detection.
In … latest advances in the nanomaterials development for cancer nanomedicine are critically …

… Nanotechnology is considered one of the alliances for cancer nanotechnology and is the
source of preclinical development of nanomaterial-based drug delivery and agents. Moreover, …

… We should evolve our nanomedicine development strategies to build the patient and disease
… the clinical development and regulatory review of nanomaterials for cancer clinical trials. …

… field, creating engineered nanomaterials with improved uniformity, … This review highlights
the developmental process of … to develop a more effective nanomedicine for cancer patients. …

… In this review, we summarized the strategies of recently developed nanomaterials, …
diagnosis of cancer [32]. In this chapter, we will introduce these various nanomaterials used …

… cancer therapeutic and diagnostic applications due to their unique characteristics of passive
tumor targeting. A wide range of nanomedicine … Development of theragnostic nanomaterials …

… A wide range of nanomaterials … developments of nanomedicine therapeutics in early and
late clinical trials. We cover opportunities to develop next-generation clinical nanomedicine …

The development of novel nanomaterials and their use in biomedicine has received much
attention in recent years. Significant advances have been made in the synthesis of …

… using nanomaterials provides new avenues for developing novel cancer therapeutics. …
In this perspective, we examine how nanomedicine can progress beyond solely providing …

… on developing novel nanomaterials for cancer therapy and … of cancer by nanomaterial-based
drug delivery strategies, in which anti-cancer drugs are loaded directly onto nanomaterials …